Long-term results of treatment of testicular tumors in children and adolescents. A retrospective analysis of a group of patients (1998–2021)
Authors:
Viera Bajčiová 1; Pavel Zerhau 2; Matěj Husár 2; Marta Ježová 3; Denisa Krejčí 4
Authors place of work:
Klinika dětské onkologie FN Brno
1; Klinika dětské chirurgie, ortopedie a traumatologie FN Brno
2; Anatomický ústav FN Brno
3; Institut biostatistiky a analýz LF MU Brno
4
Published in the journal:
Ces Urol 2022; 26(2): 99-110
Category:
Original article
Summary
Aim: Retrospective analysis of 96 patients with primary testicular cancer treated at a pediatric oncology department in the period 1998–2021. Evaluation of epidemiology, age-specific distribution of types of germinal testicular tumors, type of operation, type of chemotherapy and treatment results. Evaluation of late effects of treatment in long-term survivors.
Methods and characteristics: during the study period, 96 patients with primary testicular tumor – 89 germinal tumor type (TGCT), 6 stromal tumor type were treated. 1 patient was diagnosed with primary non-Hodgkin’s testicular lymphoma. In 1 case, the tumor was bilateral. In 58 cases, TGCT was a malignant type of tumor, and a mature prepubertal teratoma was diagnosed in 31 cases. The TGCT subtype was significantly associated with the patient’s age. Malignant tumors predominated in adolescents; in prepubertal age, most tumors were benign. Higher clinical stages (III and IV) were more common in adolescents. All patients underwent surgery – radical orchiectomy in 81 patients, testis sparing surgery (TSS) in 15 patients. Residual tumor mass surgery in metastatic patients after the end of chemotherapy took place in 9 patients, only 2 patients showed signs of vital tumor. No retroperitoneal lymph node dissection was indicated in any patient. Watch and wait strategies without adjuvant treatment were indicated in all prepubertal patients, in 14 adolescent patients and in all patients with stromal tumor type. Chemotherapy was indicated according to the type of tumor, clinical stage, age of the patient, the dynamics of the tumor markers and the classification into the risk group.
Results: All 89 patients with TGCT achieved remission. 2 patients with vital residual tumor after the end of first-line treatment achieved clinical remission after the second-line treatment. 1 patient developed metachronous malignant TGCT in the contralateral testis 7,4 years after the primary diagnosis. 1 patient developed late metastatic progression of mixed TGCT after 3,1 years and exited. 5-year overall survival (OS) is 98,7%, 5-year event free survival (EFS) is 98,7%. The median follow-up after treatment is 11,5 years. Nephrotoxicity and ototoxicity gr I and II and fertility disorders were confirmed in 11 patients. Pulmonary toxicity is present in 2 patients, 2 patients have psychological problems.
Conclusion: Testicular tumors are rare in prepubertal children, their incidence increases with age. They are the most common cancer in adolescents. The germ cell tumors are the most frequent type. The distribution of histological types of TGCT is age-specific. The patient’s prognosis depends on early diagnosis, the extent of the disease and the dynamics of the decline in tumor markers. The gold standard of treatment is radical orchiectomy, TSS is possible in a well-defined group of prepubertal boys. Chemotherapy significantly improved the prognosis of TGCT and included testicular tumors among the curative types of tumors. The risks of toxicity and late effects of treatment lead to efforts to reduce the dose and duration of chemotherapy while maintaining the results. Improving health education in adolescents is also an important factor.
Keywords:
Adolescents – analysis – children – testicular tumors
Zdroje
1. Dušek L, Abrahámová J, Lakomý R, et al. Multivariate analysis of risk factors for testicular cancer: a hospital‑based case‑control study in the Czech republic. Neoplasma. 2008; 55(4): 356–68.
2. Krejčí D, Zapletalová M, Svobodová I, et al. Childhood cancer epidemiology in the Czech republic (1994–2016). Cancer Epidemiol. 2020; 69: 101848. doi:10.1016/canep.2020.101848.
3. Jarvis H, Cost NG, Saltzman AF. Testicular tumors in the pediatric patients. Semin Ped Surg. 2021; 30: 151079.
4. Kusler KA, Poynter JN. International testicular cancer incidence rates in childen, adolescents an young adults. Cancer Epid. 2018; 56: 106–111.
5. Stein R, Quaedackers J, Bhat NR, et al. EAU‑ESPU pediatric urology guidelines on testicular tumors in prepubertal boys. J Pediatr Urol. 2021: 17: 529–533.
6. Bajčiová V. Nádory varlat u dětí, adolescentů a mladých dospělých. Rozdíly v biologii napříč věkovým spektrem. Onkológia. 2007; 2(6): 380–384.
7. Lin X, Wu D, Zheng N, et al. Gonadal germ cell tumors in children. A retrospetive review of a 10-year single‑center experience. Medicine. 2017; 96: 26–29.
8. Batool A, Karimi N, Wu XN, et al. Testicular germ cell tumor: a comprehensive review. Cell Molec Life Scien. 2019; doi.org/10.1007/s00010-019-03022-7.
9. Bajčiová V. Možnosti prevence a význam časné diagnostiky nádorů varlat u dětí a dospívajících. Current Media. 2016: 29–34.
10. Lobo J, Gillis JM, Jerónimo C, et al. Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic. Int J Mol Sci. 2019; 20: 258. doi:10.3390/ikms20020258.
11. Kooij CD, Hulsker CCC, Kraendonk MEG, et al. Testis sparing surgery in pediatric testicular tumors. Cancers. 2020; 12: 2867. doi: 10.3390/ cancers 12102867.
12. Litchfield K, Levy M, Huddart RA, et al. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment. Na Rev Urol. 2016; 13(7): 409–419.
13. Moch H, Cubilla AL, Humphrey PA, et al. The 2016 classification of tumours of the urinary system and male genital organs – part A: penile and testicular tumours. Eur Urol. 2016; 70: 93–105.
14. Looijenga LHJ, Van der Kwast TH, Grignon D, et al. Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenial Cancers. Am J Surg Pathol. 2020; 44: e66-e79.
15. Oldenburg J, Berney DM, Bokemeyer C, et al. Testicular seminoma and non‑seminoma: ESMO‑EURACAN clinical practice guideline for diagnosis, treatment and follow‑up. Ann Oncol. 2022; Jan 17: S0923-7534(22)00007-2.
16. Chieffi P. An up‑date on novel molecular targets in testicular gern cell tumors subtypes. Intractabl Rare Diseases Research. 2019; 8(2): 161–164.
17. McGlynn KA, Trabert B. Adolescent and adult risk factors for testicular cancer. Nat Rev Urol. 2014; 9(6): 339–349.
18. Elad D, Jaffa AJ, Grisaru D, et al. In utero programming of testicular cancer. J Dev Biol. 2021; 29: 9(3). dpi:10.3390/jdb9030035.
19. Woo LL, Ross JH. Partial orchiectomy vs radical orchiectomy for pediatric testis. Transl Androl Urol. 2020; 9(5): 2400–2407.
20. Maroto P, Anguera G, Martin C. Long‑term toxicity of the treatment for germ cell cancer. A review. Crit Rew Oncol. 2018; 121: 62-67.
21. Jovanovski A, Zugna D, Di Cuonzo D, et al. Quality of life among germ‑cell testicular cancer survivors: the effect of time since cancer diagnosis. Plos One. 2021; 16(20): e0258257. doi:org/10.1371/journal. pone.0258257.
22. DeSouza KW, Diniz dos Reis PE, Gomes IP. Campos de Carvalho E: Prevention strategies for testicular and penile cancer: an integrative review. Rev Esc Enferm USP. 2011; 45(1): 277–82.
23. Palmer RD, Foster NA, Vowler SL, et al. Malignant germ cell tumours of childhood: new associations of genomic imbalance. Br J Cancer. 2007; 96(4): 667–676.
24. Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Pediatr. 2001; 213(4): 204–211.
25. Zahn S, Sievers S, Alemazkour K, et al. Imbalances of chromozome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis. Genes Chromos Cancer. 2006; 45(11): 995–1006.
Štítky
Paediatric urologist Nephrology UrologyČlánok vyšiel v časopise
Czech Urology
2022 Číslo 2
Najčítanejšie v tomto čísle
- Urethral duplication in children – three cases
- A symptomatic non inflammatory paraurethral cyst in the corpus spongiosum of bulbar urethra
- Dynamic sentinel lymph node biopsy and its role in invasive staging of cN0 penile cancer. A 10-year experience of one institution
- Malignant solitary fibrous tumor of the scrotum